Colin Mann — Dalhousie University

Area of research

Infectious Diseases · Radiology, Nuclear Medicine and Imaging

Research interest

Research focused on Antibody and Virology, with related work in Immunology, Immune system, Nasal administration. Notable publications include 'Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study', 'Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination', and 'mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions'.

Recent publications

Molecular organization of the New World arenavirus spike glycoprotein complex

Nature Microbiology 2025cited by 4position: firstdoi

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

Nature Immunology 2023cited by 32position: middledoi

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

Science Translational Medicine 2022cited by 139position: middledoi

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Science 2021cited by 336position: middledoi

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination

Cell Reports Medicine 2021cited by 146position: middledoi

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Cell Reports 2021cited by 134position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Infectious Diseases · Radiology, Nuclear Medicine and Imaging →